Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant

(1) Background: SARS-CoV-2 infections are associated with an increased risk of hospital admissions especially in the elderly (age ≥ 65 years) and people with multiple comorbid conditions. (2) Methods: We investigated the effect of additional booster vaccinations following the primary vaccination ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Veronika, Polivka, Lorinc, Valyi-Nagy, Istvan, Nagy, Alexandra, Szekanecz, Zoltan, Bogos, Krisztina, Vago, Hajnalka, Kamondi, Anita, Fekete, Ferenc, Szlavik, Janos, Elek, Jeno, Surján, György, Surján, Orsolya, Nagy, Péter, Schaff, Zsuzsa, Müller, Cecília, Kiss, Zoltan, Kásler, Miklós
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321254/
https://www.ncbi.nlm.nih.gov/pubmed/35891151
http://dx.doi.org/10.3390/vaccines10070986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321254/
https://www.ncbi.nlm.nih.gov/pubmed/35891151
http://dx.doi.org/10.3390/vaccines10070986

Ejemplares similares